Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy.
about
Rapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patientsPegylated IFN-α and ribavirin: emerging data in the treatment of special populations.Causality assessment in drug-induced hepatotoxicity.Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
P2860
Hepatitis C and human immune deficiency coinfection at the era of highly active antiretroviral therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Hepatitis C and human immune d ...... active antiretroviral therapy.
@ast
Hepatitis C and human immune d ...... active antiretroviral therapy.
@en
Hepatitis C and human immune d ...... active antiretroviral therapy.
@nl
type
label
Hepatitis C and human immune d ...... active antiretroviral therapy.
@ast
Hepatitis C and human immune d ...... active antiretroviral therapy.
@en
Hepatitis C and human immune d ...... active antiretroviral therapy.
@nl
prefLabel
Hepatitis C and human immune d ...... active antiretroviral therapy.
@ast
Hepatitis C and human immune d ...... active antiretroviral therapy.
@en
Hepatitis C and human immune d ...... active antiretroviral therapy.
@nl
P2093
P2860
P1476
Hepatitis C and human immune d ...... active antiretroviral therapy.
@en
P2093
Fontaine H
Vallet-Pichard A
P2860
P356
10.1046/J.1365-2893.2002.00326.X
P577
2002-01-01T00:00:00Z